Zydus, Apollo Hospitals Partner to Expand Guardant Health’s Shield Multi-Cancer Detection Blood Test in India
Zydus Lifesciences has signed a memorandum of understanding (MoU) with Apollo Hospitals to expand access to the Shield Multi-Cancer Detection (MCD) blood test in India. The test is intended for people aged 45 years and above who are at average risk for cancer and screens for 10 common cancers. The agreement follows an exclusive arrangement…
